Verena Sigl
Impact in
- Oncology top 5%
- Bone health and treatments
- Cytokine Signaling Pathways and Interactions
- Cancer Cells and Metastasis
- Cancer Research top 10%
- NF-κB Signaling Pathways
Papers in
-
- Bone Metabolism and Diseases 6
- Epigenetics and DNA Methylation 1
- FOXO transcription factor regulation 1
- Melanoma and MAPK Pathways 1
- Oncology 6
- Bone health and treatments 6
- Cytokine Signaling Pathways and Interactions 2
- Co-authors
- Josef Penninger (8 shared papers)Daniel Schramek (4 shared papers)Reiko Hanada (2 shared papers)J. Andrew Pospisilik (2 shared papers)Manolis Pasparakis (1 shared paper)Purna A. Joshi (1 shared paper)Martin Widschwendter (1 shared paper)Antonios O. Aliprantis (1 shared paper)
- Journals
- Nature Genetics (1 paper)Trends in Endocrinology and Metabolism (1 paper)Trends in Cell Biology (1 paper)Nature (1 paper)Cytokine & Growth Factor Reviews (1 paper)
- Partner nations
- AustriaAustraliaUnited States
In The Last Decade
Verena Sigl
8 papers receiving 918 citations
Peers
Comparison fields: 5 of 72
- Oncology 533
- Cancer Research 258
- Molecular Biology 619
- Orthopedics and Sports Medicine 74
- Genetics 200
Countries citing papers authored by Verena Sigl
This map shows the geographic impact of Verena Sigl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Verena Sigl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Verena Sigl more than expected).
Fields of papers citing papers by Verena Sigl
This network shows the impact of papers produced by Verena Sigl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Verena Sigl. The network helps show where Verena Sigl may publish in the future.
Co-authors
The 25 scholars most cited alongside Verena Sigl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 423 | |
| 2 | 2011 | 111 | |
| 3 | 2017 | 104 | |
| 4 | 2011 | 76 | |
| 5 | 2017 | 65 | |
| 6 | 2016 | 53 | |
| 7 | 2014 | 50 | |
| 8 | 2011 | 46 |
About Verena Sigl
Verena Sigl is a scholar working on Molecular Biology, Oncology, Cancer Research, Pathology and Forensic Medicine and Genetics, having authored 8 papers that have together received 928 indexed citations. Recurring topics across this work include Bone health and treatments (6 papers), Bone Metabolism and Diseases (6 papers), NF-κB Signaling Pathways (3 papers), Cytokine Signaling Pathways and Interactions (2 papers), Epigenetics and DNA Methylation (1 paper), FOXO transcription factor regulation (1 paper), Genetic factors in colorectal cancer (1 paper) and Melanoma and MAPK Pathways (1 paper). The work is most often cited by research in Oncology (533 citations), Cancer Research (258 citations), Molecular Biology (619 citations), Orthopedics and Sports Medicine (74 citations) and Genetics (200 citations). Verena Sigl has collaborated with scholars based in Austria, Australia and United States. Frequent co-authors include Josef Penninger, Daniel Schramek, Reiko Hanada, J. Andrew Pospisilik, Manolis Pasparakis, Purna A. Joshi, Martin Widschwendter, Antonios O. Aliprantis, Georg Schett and Rama Khokha. Their work appears in journals such as Nature Genetics, Trends in Endocrinology and Metabolism, Trends in Cell Biology, Nature and Cytokine & Growth Factor Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.